ALPS Advisors’s MediciNova MNOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-57,340
Closed -$300K 865
2020
Q3
$300K Sell
57,340
-2,774
-5% -$16K ﹤0.01% 518
2020
Q2
$326K Sell
60,114
-19,593
-25% -$104K ﹤0.01% 533
2020
Q1
$297K Sell
79,707
-9,294
-10% -$48.4K ﹤0.01% 495
2019
Q4
$600K Buy
89,001
+2,569
+3% +$19.3K ﹤0.01% 485
2019
Q3
$688K Sell
86,432
-3,700
-4% -$33K 0.01% 397
2019
Q2
$868K Sell
90,132
-11,729
-12% -$124K 0.01% 357
2019
Q1
$843K Buy
101,861
+5,077
+5% +$44.3K 0.01% 366
2018
Q4
$791K Buy
96,784
+22,675
+31% +$226K 0.01% 355
2018
Q3
$926K Buy
74,109
+14,423
+24% +$145K 0.01% 426
2018
Q2
$475K Buy
59,686
+5,914
+11% +$61.1K ﹤0.01% 641
2018
Q1
$550K Buy
53,772
+13,768
+34% +$137K ﹤0.01% 460
2017
Q4
$259K Buy
+40,004
New +$265K ﹤0.01% 764
2016
Q4
Sell
-43,944
Closed -$329K 724
2016
Q3
$329K Sell
43,944
-1,372
-3% -$9.24K ﹤0.01% 636
2016
Q2
$342K Buy
+45,316
New +$328K ﹤0.01% 550

Other funds holding MNOV

ALPS Advisors's MNOV Position: Q4 2020 in Review

ALPS Advisors sold out of MediciNova (MNOV) in Q4 2020, closing a stake of 57,340 shares — an estimated $300K sold.

ALPS Advisors first reported a position in MNOV in Q2 2016 and held it in 14 quarters. The position peaked at $926K in Q3 2018. 57 funds tracked by Wall St. Rank hold MNOV as of Q4 2020.

  • ALPS Advisors reported no remaining MediciNova position as of Q4 2020 after selling out during the quarter.
  • ALPS Advisors sold 57,340 MediciNova shares in Q4 2020, an estimated $300K.
  • ALPS Advisors first reported a position in MediciNova in Q2 2016 and held it in 14 quarters.
  • ALPS Advisors's MediciNova position peaked at $926K in Q3 2018.
  • 57 funds tracked by Wall St. Rank held MediciNova as of Q4 2020.

Based on ALPS Advisors's 13F filing for Q4 2020, filed 3 Feb 2021.